Supernus Pharmaceuticals Inc (SUPN)
Operating Income Growth
-577.42%
Quarterly · Period ending:
SUPN Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-577.42%period ending
Latest reported-577.42%period ending
SUPN Quarterly Operating Income YoY % (-41.08% → -577.42%)
Year-over-year change
High-resolution chart · PNG
SUPN operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -577.4154% | |
| 27.4473% | |
| -35.4263% | |
| -247.4624% | |
| -46.205% | |
| -225.2775% | |
| 2,249.0964% | |
| 401.9046% | |
| 228.3277% | |
| -160.9158% | |
| -102.9009% | |
| 634.3401% | |
| -255.0062% | |
| 163.1418% | |
| 463.0371% | |
| -104.6712% | |
| -66.74% | |
| -85.1143% | |
| -85.8179% | |
| -41.9238% | |
| -25.1054% | |
| -54.4533% | |
| 5.3459% | |
| 41.3074% | |
| 6.9252% | |
| 14.0947% | |
| 2.4112% | |
| 6.0147% | |
| 19.2553% | |
| -19.0036% | |
| 16.0465% | |
| 67.7334% | |
| 37.0315% | |
| 87.0026% | |
| 110.7511% | |
| 12.6166% | |
| 149.6839% | |
| 215.6826% | |
| 137.9325% | |
| 360.4084% | |
| 239.4018% | |
| 55.0437% | |
| 44.8298% | |
| -85.2265% | |
| -18.1044% | |
| 125.5551% | |
| 141.6395% | |
| 269.8224% | |
| 124.2651% | |
| 25.0503% | |
| 10.8836% | |
| -39.7478% | |
| -67.214% | |
| -127.3166% | |
| 36.6915% | |
| -23.9536% | |
| -10.2549% | |
| 14.3509% | |
| -3.8349% | |
| -41.0759% |